Search Results - "Landman, Allison"
-
1
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Published in Nature (London) (14-02-2013)“…BRAF inhibitors such as vemurafenib have shown promising effects in patients with BRAF-mutant melanomas, but the tumours generally develop resistance;…”
Get full text
Journal Article -
2
Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage
Published in Proceedings of the National Academy of Sciences - PNAS (19-08-2008)“…Mutation of the RB-1 and p53 tumor suppressors is associated with the development of human osteosarcoma. With the goal of generating a mouse model of this…”
Get full text
Journal Article -
3
Mutationally-activated PI3’-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase
Published in eLife (27-08-2019)“…Human lung adenocarcinoma exhibits a propensity for de-differentiation, complicating diagnosis and treatment, and predicting poorer patient survival. In…”
Get full text
Journal Article -
4
Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration
Published in Human molecular genetics (15-01-2016)“…Zinc finger motifs are distributed amongst many eukaryotic protein families, directing nucleic acid-protein and protein-protein interactions. Zinc finger…”
Get full text
Journal Article -
5
SSO 2024
Published in The lancet oncology (01-05-2024)“…In a secondary analysis of the phase 2 adaptively randomised I-SPY2 trial presented by Judy C Boughey (Mayo Clinic, Rochester, MN, USA), outcomes were compared…”
Get full text
Journal Article -
6
2023 ASCO Annual Meeting
Published in The lancet oncology (01-07-2023)“…Neoadjuvant treatment in lung cancer Combining neoadjuvant pembrolizumab and ramucirumab in patients with PD-L1-positive, resectable, stage IB–IIIA…”
Get full text
Journal Article -
7
Mechanisms of Rad52-Independent Spontaneous and UV-Induced Mitotic Recombination in Saccharomyces cerevisiae
Published in Genetics (Austin) (01-05-2008)“…In wild-type diploid cells, heteroallelic recombination between his4A and his4C alleles leads mostly to His+ gene conversions that have a parental…”
Get full text
Journal Article -
8
2021 World Conference on Lung Cancer
Published in The Lancet. Oncology (01-10-2021)“…POSEIDON Melissa Johnson (Sarah Cannon Research Institute, Nashville, TN, USA) presented results from a randomised, open-label, phase 3 study of 1013 patients…”
Get full text
Journal Article Conference Proceeding -
9
ESTRO 2020 Online Congress
Published in The Lancet. Oncology (01-01-2021)“…In a study presented by Thierry De Baère (Institut Gustave Roussy, Villejuif, France), NBTXR3 at four dose levels (10%, 15%, 22%, and 33% of tumour volume) was…”
Get full text
Journal Article Conference Proceeding -
10
The G1 Cyclin Cln3 Promotes Cell Cycle Entry via the Transcription Factor Swi6
Published in Molecular and Cellular Biology (01-06-2002)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
11
Global cancer surgery: a vital service to eliminate false economy
Published in The lancet oncology (01-12-2023)“…8 years on from publication of the first surgery Commission in The Lancet Oncology, some progress has been made, such as the launch of WHO's Breast Health…”
Get full text
Journal Article -
12
49th SIOP Congress
Published in The Lancet. Oncology (01-11-2017)“…Omitting radiotherapy for Wilm's tumour Xiaofei Sun (Sun Yat Sen University Cancer Center, Guangzhou, China) presented interim results from a multicentre,…”
Get full text
Journal Article Conference Proceeding -
13
European Society of Medical Oncology 2016 Congress
Published in The Lancet. Oncology (01-11-2016)“…Selinexor in gynaecological cancer Treatment with selinexor, a first-in-class inhibitor of the nuclear export protein XPO1, led to disease control and overall…”
Get full text
Journal Article Conference Proceeding -
14
2016 ASCO Gastrointestinal Cancers Symposium
Published in The lancet oncology (01-03-2016)“…GATSBY trial Results from the adaptive phase 2/3 randomised GATSBY trial presented by Yoon-Koo Kang (University of Ulsan College of Medicine, Seoul, South…”
Get full text
Journal Article -
15
Treating childhood cancer: a necessity not a choice
Published in The lancet oncology (01-04-2020)“…Owing to population growth and inequitable access to cancer care, 80% of the global cancer burden–in terms of both incidence and mortality is estimated to fall…”
Get full text
Journal Article -
16
16th World Conference on Lung Cancer
Published in The Lancet. Oncology (01-10-2015)“…Suresh Ramalingam (Atlanta, GA, USA) presented data for an expansion cohort of AURA in which 60 patients with treatment-naive EGFR mutation-positive advanced…”
Get full text
Journal Article Conference Proceeding -
17
Working together to reduce the burden of pancreatic cancer
Published in The lancet oncology (01-03-2020)“…The global incidence of pancreatic cancer in 2017 was 5·7 per 100 000 person-years, up from 5·0 per 100 000 person-years in 1990; the number of deaths also…”
Get full text
Journal Article -
18
A genetic modifier suggests that endurance exercise exacerbates Huntington's disease
Published in Human molecular genetics (15-05-2018)“…Abstract Polyglutamine expansions in the huntingtin gene cause Huntington's disease (HD). Huntingtin is ubiquitously expressed, leading to pathological…”
Get full text
Journal Article -
19
Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAF V600E oncoprotein kinase
Published in eLife (27-08-2019)“…Human lung adenocarcinoma exhibits a propensity for de-differentiation, complicating diagnosis and treatment, and predicting poorer patient survival. In…”
Get full text
Journal Article -
20
The G(1) cyclin Cln3 promotes cell cycle entry via the transcription factor Swi6
Published in Molecular and cellular biology (01-06-2002)“…In Saccharomyces cerevisiae (budding yeast), commitment to cell division in late G(1) is promoted by the G(1) cyclin Cln3 and its associated cyclin-dependent…”
Get full text
Journal Article